chr15-100571890-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040616.3(LINS1):c.1394+4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001040616.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINS1 | ENST00000314742.13 | c.1394+4A>G | splice_region_variant, intron_variant | Intron 6 of 6 | 5 | NM_001040616.3 | ENSP00000318423.8 | |||
LINS1 | ENST00000559169.1 | n.1669+4A>G | splice_region_variant, intron_variant | Intron 1 of 1 | 2 | |||||
LINS1 | ENST00000560783.1 | n.190+1761A>G | intron_variant | Intron 1 of 3 | 5 | ENSP00000474128.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251442Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135894
GnomAD4 exome AF: 0.000172 AC: 251AN: 1461824Hom.: 0 Cov.: 31 AF XY: 0.000160 AC XY: 116AN XY: 727218
GnomAD4 genome AF: 0.000184 AC: 28AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1394+4A>G intronic variant results from an A to G substitution 4 nucleotides after coding exon 5 in the LINS gene. This nucleotide position is poorly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice donor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at